General Information


DRAVP ID  DRAVPe01749

Peptide Name   HCV gp (692–706), E2-78

Sequence  GLLHLHQNIVDVQYM

Sequence Length  15

UniProt ID  Q99IB8 

Taxon ID  None

Source  Synthetic construct

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  HCV

Assay  HCV infection assay

Activity 

  • [Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM)

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM

Binding Target  Envelope protein

Mechanism  Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C80H126N22O22S

Absent amino acids  ACEFKPRSTW

Common amino acids  L

Mass  1780.07

Pl  5.97

Basic residues  2

Acidic residues  1

Hydrophobic residues  6

Net charge  1

Boman Index  -485

Hydrophobicity  27.33

Aliphatic Index  142.67

Half Life 

  •     Mammalian:30 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  106.43

Polar residues  3



Literature Information


Literature 1

Title   A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.

Pubmed ID   28638089

Reference   A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.

Author   Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.

DOI   10.1038/s41598-017-04274-8